var data={"specialtyName":"Authors and Editors in Psychiatry","contributorTypes":[{"name":"Editors-in-Chief","contributors":[{"name":"Peter P Roy-Byrne, MD","credentials":["Editor-in-Chief — Psychiatry\n","Section Editor — Depressive Disorders\n","Professor of Psychiatry and Behavioral Sciences\n","University of Washington School of Medicine"],"disclosure":"Employment: Mass Medical Society (journal Watch); Wiley Lliss (Depression and Anxiety) [Editor in Chief]. Stock Options: Valant Medical Solutions [behavioral health (EMR)]."},{"name":"Murray B Stein, MD, MPH","credentials":["Editor-in-Chief — Psychiatry\n","Section Editor — Anxiety Disorders\n","Professor of Psychiatry and Family Medicine & Public Health\n","University of California San Diego"],"disclosure":"Grant/Research/Clinical Trial Support: Janssen [Social anxiety disorder]. Consultant/Advisory Boards: Actelion Pharmaceuticals [Anxiety and Traumatic Stress-Related Disorders]; Dart Neuroscience [Anxiety and Traumatic Stress-Related Disorders]; Janssen [Anxiety and Traumatic Stress-Related Disorders]; Oxeia Biopharmaceuticals [Traumatic Brain Injury]; Neurocrine [Tardive Dyskinesia]; Pfizer [Anxiety and Traumatic Stress-Related Disorders]. Equity Ownership/Stock Options: Oxeia Biopharmaceuticals [Traumatic Brain Injury]; Resilience Therapeutics [PTSD]."}]},{"name":"Deputy Editors","contributors":[{"name":"Richard Hermann, MD","credentials":["Deputy Editor — Psychiatry\n","Associate Professor\n","Tufts University School of Medicine"],"disclosure":""},{"name":"David Solomon, MD","credentials":["Deputy Editor — Psychiatry\n","Clinical Associate Professor\n","Brown University School of Medicine"],"disclosure":""}]},{"name":"Section Editors","contributors":[{"name":"David Brent, MD","credentials":["Section Editor — Childhood Mental Disorders \n","Professor of Psychiatry, Pediatrics and Epidemiology\n","University of Pittsburgh School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: NIMH [Child & Adolescent Psychiatry]; AFSP [Suicide prevention]. Consultant/Advisory Boards: Healthwise [Consumer health education (Child Psychiatry)]; Klingenstein Third Generation Foundation [Postdoctoral fellowships]. Patent Holder: Guilford Press [Psychology (Treating depressed and suicidal adolescents)]; ERT Inc [Cloud platform solution (C-SSRS)]. Other Financial Interest: Guilford Press [Psychology (Treating depressed and suicidal adolescents)]; ERT Inc [Cloud platform solution (C-SSRS)]."},{"name":"Joel Dimsdale, MD","credentials":["Section Editor — Somatic Symptom and Related Disorders\n","Professor of Psychiatry\n","University of California, San Diego"],"disclosure":""},{"name":"Paul Keck, MD","credentials":["Section Editor — Bipolar Disorders\n","Professor of Psychiatry\n","University of Cincinnati College of Medicine"],"disclosure":"Consultant/Advisory Boards: Otsuka [Bipolar disorder (Aripiprazole)]; Lyndra. Patent Holder: US Patent [Obsessive-compulsive disorder (Tramadol)]."},{"name":"Stephen Marder, MD","credentials":["Section Editor — Psychotic Disorders\n","Professor of Psychiatry\n","Semel Institute of Neuroscience at UCLA"],"disclosure":"Grant/Research/Clinical Trial Support: Forum; Neurocrine [schizophrenia and tardive dyskinesia]. Consultant/Advisory Boards: Takeda, Gideon Richter, Boeringer-Ingleheim, Otsuka; Allergan; Teva [schizophrenia (brexpiprazole, cariprazine)]."},{"name":"Susan McElroy, MD","credentials":["Section Editor — Impulse Control Disorders\n","Professor of Psychiatry\n","University of Cincinnati"],"disclosure":"Grant/Research/Clinical Support: Allergan [Depression]; Brainsway [Smoking & OCD (Transcranial magnetic stimulation)]; Marriott Foundation [Bipolar disorder]; Myriad [Bipolar disorder]; Naurex [Depression (GLYX-13)]; Novo Nordisk [Obesity, Bipolar disorder]; Shire [Binge eating disorder (Lisdexamfetamine)]; Sunovion[Binge eating disorder]. Consultant/Advisory Boards: Bracket [Psychiatry]; F Hoffman La Roche, [Psychiatry]; MedAvante [Psychiatry]; Mitsubishi Tanabe Pharma America; Myriad [Bipolar disorder]; Novo Nordisk [Binge eating disorder]; Shire [Binge eating disorder (Lisdexamfetamine)]; Sunovion [Binge eating disorder]. Consultant/Advisory Boards (spouse): Shire [Bipolar disorder]; Supernus [Bipolar disorder]; Otsuka [Bipolar disorder]; ProPhase [Bipolar disorder]; Merck [Bipolar disorder]."},{"name":"Peter P Roy-Byrne, MD","credentials":["Editor-in-Chief — Psychiatry\n","Section Editor — Depressive Disorders\n","Professor of Psychiatry and Behavioral Sciences\n","University of Washington School of Medicine"],"disclosure":"Employment: Mass Medical Society (journal Watch); Wiley Lliss (Depression and Anxiety) [Editor in Chief]. Stock Options: Valant Medical Solutions [behavioral health (EMR)]."},{"name":"Richard Saitz, MD, MPH, FACP, DFASAM","credentials":["Section Editor — Substance Use Disorders\n","Professor of Community Health Sciences and Medicine\n","Boston University Schools of Public Health and Medicine, Boston Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Alkermes [Alkermes provides study medication for a clinical trial supported by NIH on Alcohol user disorder (injectable naltrexone)]."},{"name":"Andrew J Saxon, MD","credentials":["Section Editor — Substance Use Disorders\n","Professor and Director, Addiction Psychiatry Residency Program, Department of Psychiatry & Behavioral Sciences\n","University of Washington"],"disclosure":"Grant/Research/Clinical Trial Support: Medicasafe [Medication dispensing]. Consultant/Advisory Boards: Neurocrine Biosciences [Tardive dyskinesia (Valbenazine)]."},{"name":"Jonathan M Silver, MD","credentials":["Section Editor — Mental and Medical Disorders\n","Clinical Professor of Psychiatry\n","New York University School of Medicine"],"disclosure":""},{"name":"Andrew Skodol, MD","credentials":["Section Editor — Personality Disorders\n","Research Professor of Psychiatry\n","University of Arizona College of Medicine"],"disclosure":"Other Financial Interest: American Psychiatric Publishing (royalties); Merck Manuals (royalties)."},{"name":"David Spiegel, MD","credentials":["Section Editor — Dissociative Disorders\n","Professor of Psychiatry and Behavioral Sciences\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Murray B Stein, MD, MPH","credentials":["Editor-in-Chief — Psychiatry\n","Section Editor — Anxiety Disorders\n","Professor of Psychiatry and Family Medicine & Public Health\n","University of California San Diego"],"disclosure":"Grant/Research/Clinical Trial Support: Janssen [Social anxiety disorder]. Consultant/Advisory Boards: Actelion Pharmaceuticals [Anxiety and Traumatic Stress-Related Disorders]; Dart Neuroscience [Anxiety and Traumatic Stress-Related Disorders]; Janssen [Anxiety and Traumatic Stress-Related Disorders]; Oxeia Biopharmaceuticals [Traumatic Brain Injury]; Neurocrine [Tardive Dyskinesia]; Pfizer [Anxiety and Traumatic Stress-Related Disorders]. Equity Ownership/Stock Options: Oxeia Biopharmaceuticals [Traumatic Brain Injury]; Resilience Therapeutics [PTSD]."},{"name":"Joel Yager, MD","credentials":["Section Editor — Eating Disorders\n","Professor of Psychiatry\n","University of Colorado School of Medicine"],"disclosure":""}]},{"name":"Editorial Assistants","contributors":[{"name":"Jamie Spagnuolo, BA","credentials":["Editorial Assistant — UpToDate"],"disclosure":""}]},{"name":"Authors","contributors":[{"name":"Jonathan Abramowitz, PhD","credentials":["Professor of Psychology\n","University of North Carolina at Chapel Hill"],"disclosure":""},{"name":"Nezam H Afdhal, MD, FRCPI","credentials":["Senior Physician in Hepatology\n","Beth Israel Deaconess Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie; BMS; Gilead [HCV Studies]. Consultant/Advisory Boards: AbbVie; Echosens; Gilead Sciences; GlaxoSmithKline; Jannsen Pharmaceutica; Ligand; Merck & Co; Novartis International AG; Spring Bank Pharmaceuticals; TRIO HealthCare [Liver Disease]. Equity Ownership/Stock Options: Spring Bank Pharmaceuticals [HBV, RSV]. Employment: Spring Bank Pharmaceuticals [HBV, RSV] - No relevant conflict on topic."},{"name":"Marc Agronin, MD","credentials":["Associate Professor of Psychiatry and Neurology\n","University of Miami Miller School of Medicine"],"disclosure":""},{"name":"Ann Marie Albano, PhD, ABPP","credentials":["Professor of Medical Psychology (in Psychiatry)\n","Columbia University"],"disclosure":"Consultant/Advisory Boards: University of Maryland for NIMH [Anxiety]. Other Financial Interest: Oxford Press [Anxiety (Royalties)]."},{"name":"Pino Alonso, MD, PhD","credentials":["Assistant Professor\n","University of Barcelona"],"disclosure":""},{"name":"Evan Alvarez, MA","credentials":["Research Project Coordinator\n","Columbia University, New York State Psychiatric Institute"],"disclosure":""},{"name":"J Todd Arnedt, PhD","credentials":["Associate Professor, Departments of Psychiatry and Neurology\n","University of Michigan Medical School"],"disclosure":""},{"name":"Mark D Aronson, MD","credentials":["Editor-in-Chief — Primary Care (Adult); Hospital Medicine\n","Section Editor — General Medicine\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Evelyn Attia, MD","credentials":["Professor of Psychiatry\n","Columbia University Medical Center"],"disclosure":"Grant/Research Support: Eli Lilly [Eating disorders (Olanzapine)]."},{"name":"Marilyn Augustyn, MD","credentials":["Section Editor — Developmental and Behavioral Pediatrics\n","Associate Professor\n","Boston University School of Medicine"],"disclosure":""},{"name":"David Avery, MD","credentials":["Professor of Psychiatry and Behavioral Sciences\n","University of Washington School of Medicine"],"disclosure":""},{"name":"David Axelson, MD","credentials":["Professor of Psychiatry\n","The Ohio State University College of Medicine"],"disclosure":"Consultant/Advisory Boards: Janssen Research [Bipolar disorder (Risperidone)]."},{"name":"Sudie E Back, PhD","credentials":["Professor\n","Medical University of South Carolina"],"disclosure":"Grant/Research/Clinical Trial Support: National Institute of Health; US Department of Defense; US Department of Veteran Affairs [PTSD and SUD (COPE treatment therapy manual and patient workbook)]."},{"name":"David Baldwin, MA, DM FRCPsych","credentials":["Professor of Psychiatry and Head of Mental Health Group\n","University of Southampton Faculty of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [GAD (Pregabalin)]. Consultant/Advisory Boards: Lundbeck [Depression (Vortioxetine)]; LivaNova [Depression (VNS)]; Mundipharma [Anxiety (methoxyflurane)]. Other Financial Interest: AstraZeneca [Depression (Quetiapine)]."},{"name":"David Baron, MSEd, DO, DFAPA","credentials":["Professor and Vice chair, Department of Psychiatry\n","Keck School of Medicine at USC"],"disclosure":"Grant/Research/Clinical Trial Support: NIMH [consultant (NFL, NCAA/PAC-12)]."},{"name":"William C Becker, MD","credentials":["Assistant Professor of Medicine\n","Yale University School of Medicine"],"disclosure":""},{"name":"Donna Bender, PhD","credentials":["Clinical Professor of Psychiatry and Behavioral Sciences\n","Tulane University"],"disclosure":""},{"name":"David Benedek, MD","credentials":["Professor and Chair\n","Uniformed Services University School of Medicine"],"disclosure":""},{"name":"Shannon Bennett, PhD","credentials":["Assistant Professor of Psychology in Psychiatry\n","Weill Cornell Medical College"],"disclosure":""},{"name":"Boris Birmaher, MD","credentials":["Endowed Chair in Early Onset Bipolar Disease, Professor of Psychiatry\n","University of Pittsburgh, School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: National Institutes of Mental Health [Bipolar disorder]. Other Financial Interests: Royalties for books [Bipolar and major depressive disorders]."},{"name":"Robert J Birnbaum, MD, PhD","credentials":["Assistant Professor of Psychiatry\n","Harvard Medical School"],"disclosure":""},{"name":"Donald W Black, MD","credentials":["Professor of Psychiatry\n","University of Iowa Carver College of Medicine"],"disclosure":""},{"name":"William V Bobo, MD, MPH","credentials":["Professor of Psychiatry\n","Mayo College of Medicine"],"disclosure":""},{"name":"Liza Bonin, PhD","credentials":["Associate Professor of Pediatrics and Psychiatry\n","Baylor College of Medicine"],"disclosure":""},{"name":"Andrea Bradford, PhD","credentials":["Baylor College of Medicine\n","Department of Medicine - Section of Gastroenterology"],"disclosure":""},{"name":"Kathleen Brady, MD, PhD","credentials":["Professor of Psychiatry\n","Medical University of South Carolina"],"disclosure":""},{"name":"Raphael J Braga, MD","credentials":["Assistant Professor of Psychiatry\n","Hofstra University/Northwell Health\n","Center for Treatment and Research of Bipolar Disorder\n","The Zucker Hillside Hospital"],"disclosure":""},{"name":"Bethany Brand, PhD","credentials":["Professor of Psychology \n","Towson University"],"disclosure":""},{"name":"David Brent, MD","credentials":["Section Editor — Childhood Mental Disorders \n","Professor of Psychiatry, Pediatrics and Epidemiology\n","University of Pittsburgh School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: NIMH [Child & Adolescent Psychiatry]; AFSP [Suicide prevention]. Consultant/Advisory Boards: Healthwise [Consumer health education (Child Psychiatry)]; Klingenstein Third Generation Foundation [Postdoctoral fellowships]. Patent Holder: Guilford Press [Psychology (Treating depressed and suicidal adolescents)]; ERT Inc [Cloud platform solution (C-SSRS)]. Other Financial Interest: Guilford Press [Psychology (Treating depressed and suicidal adolescents)]; ERT Inc [Cloud platform solution (C-SSRS)]."},{"name":"Richard Bryant, PhD","credentials":["Professor of Psychology\n","University of New South Wales"],"disclosure":""},{"name":"Robert W Buchanan, MD","credentials":["Professor of Psychiatry\n","University of Maryland School of Medicine"],"disclosure":""},{"name":"Oscar Bukstein, MD","credentials":["Professor of Psychiatry\n","Harvard Medical School"],"disclosure":""},{"name":"Brenda Bursch, PhD","credentials":["Professor of Clinical Psychiatry & Biobehavioral Sciences, and Pediatrics\n","David Geffen School of Medicine at UCLA"],"disclosure":""},{"name":"Juan Bustillo, MD","credentials":["Professor of Psychiatry & Neuroscience\n","University of New Mexico"],"disclosure":""},{"name":"Alexander Bystritsky, MD, PhD","credentials":["Professor of Psychiatry and Biobehavioral Sciences Director,\n","Anxiety Disorders Program, David Geffen School of Medicine, University of California, Los Angeles"],"disclosure":""},{"name":"John S Cacciola, PhD","credentials":["Senior Scientist\n","Treatment Research Institute\n","Adjunct Professor of Psychology in Psychiatry\n","Perelman School of Medicine at University of Pennsylvania"],"disclosure":""},{"name":"Eve Caligor, MD","credentials":["Clinical Professor of Psychiatry\n","Columbia University College of Physicians and Surgeons"],"disclosure":""},{"name":"Austin R Campbell, PharmD, BCPP","credentials":["Adjunct Clinical Assistant Professor of Psychiatry \n","University of Missouri School of Medicine and University of Missouri - Kansas City School of Pharmacy"],"disclosure":""},{"name":"E Cabrina Campbell, MD","credentials":["Associate Professor of Psychiatry\n","Perelman School of Medicine, University of Pennsylvania; Cpl. Michael J. Crescenz VA Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Sunovian [Schizophrenia/bipolar depression(lurasidone)]."},{"name":"Stanley N Caroff, MD","credentials":["Professor of Psychiatry\n","Perelman School of Medicine, University of Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support:Neurocrine Biosciences, Inc.(Valbenazine). Consultant/Advisory Boards: Neurocrine Biosciences, Inc. (Valbenazine); Teva Pharmaceuticals, Inc. (Austedo)."},{"name":"Peijun Chen, MD, MPH, PhD","credentials":["Associate Professor of Psychiatry\n","Case Western Reserve University School of Medicine\n","Staff Geriatric Psychiatrist, Louis Stokes Cleveland VA Medical Center"],"disclosure":""},{"name":"Yujuan Choy, MD","credentials":["Assistant Clinical Professor of Psychiatry (volunteer faculty)\n","University of California, Irvine"],"disclosure":""},{"name":"Emil Coccaro, MD","credentials":["Professor of Psychiatry and Behavioral Neuroscience\n","The University of Chicago"],"disclosure":"Consultant/Advisory Boards: Azevan Inc [Intermittent explosive disorder]; Avanir, Inc [Intermittent explosive disorder]. Equity Ownership/Stock Options: Azevan Inc [Aggression]."},{"name":"M Justin Coffey, MD","credentials":["Associate Professor of Psychiatry & Behavioral Sciences\n","Baylor College of Medicine"],"disclosure":""},{"name":"Phillip Coffin, MD, MIA","credentials":["Director of Substance Use Research\n","Center for Public Health Research, San Francisco Department of Public Health"],"disclosure":""},{"name":"Judith A Cohen, MD","credentials":["Professor of Psychiatry\n","Drexel University College of Medicine"],"disclosure":"Grant/ Research Support: NIMH; NICHD; SAMHSA [TF-CBT research]. Other Financial Interest: Guilford Press  [TF-CBT (TF-CBT treatment books)]."},{"name":"Francesc Colom, PhD, PsyD, MSc","credentials":["Senior Researcher\n","Mental Health Program\n","Hospital del Mar Medical Research Institute\n","CIBERSAM"],"disclosure":""},{"name":"K Ryan Connolly, MD, MS","credentials":["Clinical Assistant Professor of Psychiatry\n","University of Pennsylvania School of Medicine"],"disclosure":""},{"name":"Christoph U Correll, MD","credentials":["Professor of Psychiatry and Molecular Medicine\n","Hofstra Northwell School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Takeda [Schizophrenia, Depression (lurasidone, Vortioxetine)]. Consultant/Advisory Boards: Alkermes [Schizophrenia, Depression(Aripiprazole Lauroxil, ALKS-3831,ALKS-5461)]; Bristol-Meyers Squibb[Schizophrenia( Aripiprazole )]; Forum[Schizophrenia( Encenicline)]; IntraCellular Therapies[Schizophrenia( ITI-007)];  Janssen/J&J[Schizophrenia( Risperdal Consta, Paliperidone Palmitate)]; LB Pharma [Schizophrenia( Amisulpride)]; Lundbeck [Schizophrenia,(Abilify Maintena)], [Depression (Brexpiprazole, Vortioxetine, Lu AF35700)]; Neurocrine[Schizophrenia( Valbenazine)]; Otsuka[Schizophrenia,( Abilify Maintena, Brexpiprazole)],[Depression(Brexpiprazole, Vortioxetine)]; Pfizer[Schizophrenia( Ziprasidone)]; Sunovion[Schizophrenia( Lurasidone)]; Supernus[Schizophrenia( Molindone-ER)]; Takeda[Schizophrenia,( Lurasidone)]; [Depression(Vortioxetine)]; Teva [Schizophrenia( Subcutaneous injectable antipsychotic formulations)]."},{"name":"William Coryell, MD","credentials":["Professor of Psychiatry\n","University of Iowa, Carver College of Medicine"],"disclosure":""},{"name":"Michelle Craske, PhD","credentials":["Director, Anxiety Research Center\n","University of California, Los Angeles Department of Psychology"],"disclosure":"Grant/Research/Clinical Trial Support: National Institute of Mental Health [Anxiety and depression (Cognitive and behavioral treatment)]. Other Financial Interest: Oxford University Press [Cognitive and behavioral therapy for anxiety disorders (Book royalties)]."},{"name":"Scott J Crow, MD","credentials":["Professor of Psychiatry\n","University of Minnesota"],"disclosure":""},{"name":"Larry Culpepper, MD, MPH","credentials":["Professor of Family Medicine\n","Boston University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Jazz [Behavioral health-sleep (solriamfetol)]; Lundbeck A/S [Behavioral health (vortioxetine)]; Merck [Behavioral health (suvorexant)]; Sunovion Pharmaceuticals Inc [Behavioral health (lurasidone)]. Equity Ownership/Stock Options: M-3 Information, LLC [Behavioral health (My Mood Monitor)]. Other Financial Interest: Physicians Postgraduate Press [Behavioral health (Editor in Chief of the \"Primary Care Companion for CNS Diseases\")]."},{"name":"Colin S Cunningham, PhD","credentials":["Baltimore, MD"],"disclosure":""},{"name":"Michael Davis, MD, PhD","credentials":["Assistant Professor of Psychiatry & Behavioral Sciences\n","Baylor College of Medicine"],"disclosure":""},{"name":"Pelle P de Koning, MD","credentials":["Department of Psychiatry, Academic Medical Center (AMC), \n","University of Amsterdam, Amsterdam, The Netherlands"],"disclosure":""},{"name":"Valdesha DeJean, MD","credentials":["Pacific Medical Centers - Canyon Park Clinic"],"disclosure":""},{"name":"Damiaan Denys, MD, PhD","credentials":["Professor of Psychiatry\n","Academic Medical Center, University of Amsterdam\n","Netherlands Institute for Neuroscience, an institute of the KNAW, Amsterdam"],"disclosure":"Other Financial Interest: Medtronic [DBS (DBS research)]."},{"name":"Michael Devlin, MD","credentials":["Professor of Clinical Psychiatry\n","Columbia University College of Physicians and Surgeons"],"disclosure":""},{"name":"Alice D Domar, PhD","credentials":["Associate Professor of Obstetrics, Gynecology and Reproductive Biology (part-time)\n","Harvard Medical School"],"disclosure":"Speaker's Bureau: Merck [Stress and stress reduction]; Ferring [Stress and stress reduction]. Equity Ownership/Stock Options: TriaDea [Impact of supplements on fertility (Vitamins/supplements)]; FertiCalm (App to teach mind/body skills to infertility patients); FertiStrong (App to teach mind/bpdy skills to men experiencing infertility)."},{"name":"Frank J Domino, MD","credentials":["Professor of Family Medicine\n","University of Massachusetts Medical School"],"disclosure":""},{"name":"Karen L Dugosh, PhD","credentials":["Senior Scientist\n","Treatment Research Institute"],"disclosure":""},{"name":"Yael Dvir, MD","credentials":["Assistant Professor of Psychiatry\n","University of Massachusetts Medical School"],"disclosure":""},{"name":"Scott Engel, PhD","credentials":["Research Scientist\n","Neuropsychiatric Research Institute"],"disclosure":""},{"name":"Randall T Espinoza, MD, MPH","credentials":["Clinical Professor of Psychiatry\n","University of California, Los Angeles"],"disclosure":""},{"name":"Lorena Fernández de la Cruz, PhD","credentials":["Assistant Professor\n","Karolinska Institutet"],"disclosure":""},{"name":"Bernard A Fischer, MD","credentials":["Assistant Professor of Psychiatry\n","University of Maryland School of Medicine"],"disclosure":""},{"name":"Brad Foote, MD","credentials":["Associate Clinical Professor\n","Albert Einstein College of Medicine, Yeshiva University"],"disclosure":""},{"name":"Sara F Forman, MD","credentials":["Assistant Professor in Pediatrics\n","Harvard Medical School"],"disclosure":"Other Financial Interest: Pediatric endocrine meeting [Eating disorders (Honorarium)]."},{"name":"Jean Frazier, MD","credentials":["Professor of Psychiatry and Pediatrics\n","University of Massachusetts Medical School"],"disclosure":"Grant/Research Support: NIMH; NICHD; Alcobra [Fragile X Syndrome (Metadoxine M601C1)]; Neuren [Fragile X Syndrome (Glycyl-L-2-Methylpropyl-L-Glutamic Acid)]; Roche [Fragile X Syndrome (Metabotropic Glutamate 5 Negative Allosteric Modulator)]; SyneuRx [Schizophrenia (Sodium Benzoate)]. Other Financial Interest: Forest [Depression (Vilazodone)]; Data Safety Monitoring Board."},{"name":"Oliver Freudenreich, MD","credentials":["Associate Professor of Psychiatry\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Avanir [Schizophrenia (AVP-786)]; Janssen [Schizophrenia (long-acting injectable)]; Otsuka [Schizophrenia (brexpiprazole)]. Consultant/Advisory Boards: Janssen [Schizophrenia drug development]. Other Financial Interest: Global Medical Education [CME talk on schizophrenia]."},{"name":"Paul A Frewen, PhD","credentials":["Assistant Professor of Psychiatry\n","University of Western Ontario"],"disclosure":""},{"name":"Glen Gabbard, MD","credentials":["Professor of Psychiatry\n","SUNY Upstate Medical University\n","Clinical Professor of Psychiatry\n","Baylor College of Medicine"],"disclosure":""},{"name":"Bradley N Gaynes, MD, MPH","credentials":["Professor of Psychiatry, Associate Chair for Psychiatry Research Training and Education \n","University of North Carolina School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: M-3 [Research to assess feasibility of administering a general psychiatric screening and monitoring tool in psychiatric clinics]."},{"name":"Michael Gitlin, MD","credentials":["Professor of Clinical Psychiatry\n","Geffen School of Medicine at UCLA"],"disclosure":""},{"name":"Andrew Goddard, MD","credentials":["Professor of Psychiatry, UCSF\n","UCSF Fresno Medical Education & Research Program"],"disclosure":"Grant/Research/Clinical Trial Support: Central California Faculty Medical Group [Anxiety disorder (Suvorexant)]; National Network of Depression Centers [Multisite trial of biomarkers of ketamine response in TRD]."},{"name":"Adam J Gordon, MD, MPH, FACP, FASAM","credentials":["Professor of Medicine and Psychiatry\n","University of Utah School of Medicine"],"disclosure":""},{"name":"David A Gorelick, MD, PhD","credentials":["Professor of Psychiatry\n","University of Maryland School of Medicine"],"disclosure":""},{"name":"Leah Gramlich, MD, FRCPC","credentials":["Professor of Medicine\n","University of Alberta"],"disclosure":"Speaker's Bureau: Abbott [malnutrition (Ensure)]."},{"name":"Sophie Grigoriadis, MD, MA, PhD, FRCPC","credentials":["Associate Professor of Psychiatry\n","University of Toronto\n","Sunnybrook Health Sciences Centre"],"disclosure":"Speaker's Bureau: Pfizer [Depression]. Consultant/Advisory Boards: Allergan [Depression (Levomilnacipran)]; Actavis [Depression (Vilazodone)]; Sage [Postpartum depression]."},{"name":"Derrick Hamaoka, LtCol, USAF, MC, FS","credentials":["Associate Professor\n","Uniformed Services University of the Health Sciences"],"disclosure":""},{"name":"Karen Hartwell, MD","credentials":["Associate Professor\n","Medical University of South Carolina"],"disclosure":""},{"name":"Victoria Hendrick, MD","credentials":["Clinical Professor\n","Department of Psychiatry and Biobehavioral Sciences David Geffen School of Medicine, UCLA"],"disclosure":""},{"name":"Richard Hermann, MD","credentials":["Deputy Editor — Psychiatry\n","Associate Professor\n","Tufts University School of Medicine"],"disclosure":""},{"name":"Michael Hirsch, MD","credentials":["Instructor in Psychiatry\n","Harvard Medical School"],"disclosure":""},{"name":"Stefan G Hofmann, PhD","credentials":["Professor of Psychology\n","Boston University"],"disclosure":""},{"name":"Jean L Holley, MD, FACP","credentials":["Clinical Professor of Medicine\n","University of Illinois, Urbana-Champaign"],"disclosure":""},{"name":"Stephen R Holt, MD, MS, FACP","credentials":["Assistant Professor of Medicine\n","Yale School of Medicine"],"disclosure":""},{"name":"Paul E Holtzheimer, MD","credentials":["Associate Professor of Psychiatry and Surgery\n","The Geisel School of Medicine at Dartmouth"],"disclosure":"Grant/Research/Clinical Trial Support: NeoSync [Depression (TMS device)]."},{"name":"Karen Ingersoll, PhD","credentials":["Associate Professor of Psychiatry and Neurobehavioral Sciences\n","University of Virginia School of Medicine"],"disclosure":""},{"name":"Michael R Irwin, MD","credentials":["Cousins Professor of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA\n","Professor of Psychology, UCLA College of Letters and Sciences"],"disclosure":""},{"name":"Philip G Janicak, MD","credentials":["Adjunct Professor, Department of Psychiatry and Behavioral Sciences\n","Northwestern University, Feinberg School of Medicine"],"disclosure":"Speaker's Bureau: Neuronetics [Depression (transcranial magnetic stimulation)]; TMS Solutions [Depression (transcranial magnetic stimulation)]. Consultant/ Advisory Boards: Neuronetics [Depression (transcranial magnetic stimulation)]; Otsuka [Psychosis (participate in their nonpromotional PsyhU program on various topics, including mood and psychotic disorders)]."},{"name":"Robin B Jarrett, PhD","credentials":["Elizabeth H. Penn Professor in Clinical Psychology\n","The University of Texas Southwestern Medical Center"],"disclosure":""},{"name":"Michael D Jibson, MD, PhD","credentials":["Professor of Psychiatry\n","University of Michigan"],"disclosure":""},{"name":"Bankole A Johnson, DSc, MD, MBChB, MPhil, FRCPsych, DFAPA","credentials":["The Dr. Irving J. Taylor Professor and Chair in the Department of Psychiatry\n","Professor of Pharmacology and Professor of Anatomy & Neurobiology\n","Director of the Brain Science Research Consortium \n","University of Maryland School of Medicine"],"disclosure":"Consultant/Advisory Boards: ADial Pharmaceuticals [Addiction (Ondansetron)]; D&A Pharma [Addiction]. Equity Ownership/Stock Options: ADial Pharmaceuticals [Addiction (Ondansetron)]; Kole Life Foods [Food and wellness products]; Pepco [Psychological services (Brief behavioral compliance enhancement treatment)]."},{"name":"Kyle Kampman, MD","credentials":["Associate Professor of Psychiatry\n","Perelman School of Medicine, University of Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support: Braeburn [Opioid use disorder]."},{"name":"John Kane, MD","credentials":["Professor of Psychiatry and Molecular Medicine\n","Hofstra Northwell School of Medicine"],"disclosure":"Consultant/Advisory Boards: Alkermes [Schizophrenia (Aripiprazole)]; Lundbeck [Schizophrenia (Long-acting aripiprazole)]; Intracellular Therapeutics [Drug development]; Janssen Pharmaceutica [Schizophrenia (Risperidone, paliperidone)]; Johnson and Johnson [Schizophrenia (Risperidone, paliperidone)]; Otsuka [Schizophrenia (Aripiprazole)]; Reviva [Drug development]; Roche [Drug development]; Sunovion [Schizophrenia  (Lurasidone)]; Teva [Drug development]. Equity Ownership/Stock Options: MedAvante, Inc [Assessment in clinical trials]; Vanguard Research Group [Conduct of clinical trials]; LB Pharmaceuticals, Inc [Drug development]. Other Financial Interest: Janssen; Genentech; Otsuka (honoraria)."},{"name":"Jason Karlawish, MD","credentials":["Professor of Medicine\n","Medical Ethics and Health Policy\n","University of Pennsylvania"],"disclosure":""},{"name":"Brooks Keeshin, MD","credentials":["Assistant Professor of Pediatrics\n","University of Utah"],"disclosure":""},{"name":"Gabor Keitner, MD","credentials":["Professor of Psychiatry\n","Brown University"],"disclosure":""},{"name":"Charles Kellner, MD","credentials":["Professor of Psychiatry\n","Icahn School of Medicine at Mount Sinai"],"disclosure":"Other Financial Interest: Cambridge University Press (honoraria); Psychiatric Times (paid contributor); Northwell Health (honoraria for teaching ECT course)."},{"name":"Stephanie Kennebeck, MD","credentials":["Associate Professor of Clinical Pediatrics\n","Cincinnati Children’s Hospital Medical Center\n","University of Cincinnati School of Medicine"],"disclosure":""},{"name":"Jay S Keystone, MD, MSc (CTM), FRCPC","credentials":["Professor of Medicine\n","University of Toronto, Canada"],"disclosure":""},{"name":"Mary C Kimmel, MD","credentials":["Clinical Assistant Professor of Psychiatry\n","UNC Chapel Hill"],"disclosure":"Equity Ownership/Stock Options (Spouse): Abbvie and Abbott Laboratories."},{"name":"Taishiro Kishimoto, MD","credentials":["Assistant Professor of Neuropsychiatry \n","Keio University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Otsuka [Schizophrenia (Aripiprazole)]. Speaker’s Bureau: Otsuka [Schizophrenia (Aripiprazole)]; Lilly [Schizophrenia (Olanzapine)]; Janssen [Schizophrenia (Risperidone, Paliperidone)]."},{"name":"Diane Klein, MD","credentials":["Associate Professor of Clinical Psychiatry\n","New York University School of Medicine"],"disclosure":""},{"name":"Ranga Krishnan, MD","credentials":["Professor of Psychiatry\n","Duke University School of Medicine"],"disclosure":""},{"name":"Ralph Kupka, MD, PhD","credentials":["Professor of Psychiatry \n","VU University Medical Center, Amsterdam, the Netherlands"],"disclosure":"Speaker's Bureau: AstraZeneca; Lundbeck [Bipolar disorder (aripiprazole)]."},{"name":"Ruth Lanius, MD, PhD","credentials":["Professor of Psychiatry\n","The University of Western Ontario"],"disclosure":""},{"name":"John Lauriello, MD","credentials":["Professor of Psychiatry\n","University of Missouri"],"disclosure":"Grant/Research/Clinical Trial Support: Otsuka; Alkermes [Schizophrenia (Lurasidone, Aripiprazole LAI, Paliperidone LAI)]. Consultant/Advisory Boards: Sunovion; Janssen; Otsuka; Reckitt; Benckiser [Schizophrenia (Lurasidone, Paliperidone LAI, Aripiprazole LAI)]; Teva [Tardive dyskinesia (Medication not yet approved)]."},{"name":"Kimberly Glazier Leonte, PhD","credentials":["Clearview Horizons"],"disclosure":""},{"name":"James L Levenson, MD","credentials":["Professor of Psychiatry, Medicine, and Surgery\n","Virginia Commonwealth University School of Medicine"],"disclosure":""},{"name":"Stephen B Levine, MD","credentials":["Clinical Professor of Psychiatry\n","Case Western Reserve University School of Medicine"],"disclosure":""},{"name":"Mitchell Levy, MD","credentials":["Assistant Professor of Health Services and Psychiatric Epidemiology\n","University of Washington School of Medicine"],"disclosure":""},{"name":"Richard J Loewenstein, MD","credentials":["Medical Director, The Trauma Disorders Program\n","Sheppard Pratt Health System"],"disclosure":""},{"name":"Julie Lord, MD","credentials":["Assistant Residency Training Director,\n","University of Washington Outpatient Psychiatry Clinic"],"disclosure":""},{"name":"Jeffrey M Lyness, MD","credentials":["Senior Associate Dean for Academic Affairs\n","Professor of Psychiatry and Neurology\n","University of Rochester Medical Center"],"disclosure":""},{"name":"Stephan C Mann, MD, DLFAPA","credentials":["Lenape Valley Foundation"],"disclosure":""},{"name":"Theo Manschreck, MD","credentials":["Professor of Psychiatry\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Otsuka [early psychosis (aripiprazole)]. Consultant/Advisory Boards: Otsuka-Lundbeck [new antidepressant]."},{"name":"Stephen Marder, MD","credentials":["Section Editor — Psychotic Disorders\n","Professor of Psychiatry\n","Semel Institute of Neuroscience at UCLA"],"disclosure":"Grant/Research/Clinical Trial Support: Forum; Neurocrine [schizophrenia and tardive dyskinesia]. Consultant/Advisory Boards: Takeda, Gideon Richter, Boeringer-Ingleheim, Otsuka; Allergan; Teva [schizophrenia (brexpiprazole, cariprazine)]."},{"name":"Scott F Martin, MD","credentials":["Clinical Instructor\n","Case Western Reserve University School of Medicine"],"disclosure":""},{"name":"David Mataix-Cols, PhD","credentials":["Professor of Child and Adolescent Psychiatric Science\n","Karolinska Institutet"],"disclosure":""},{"name":"Randi E McCabe, PhD","credentials":["Professor of Psychiatry & Behavioural Neurosciences\n","McMaster University"],"disclosure":""},{"name":"Joseph McEvoy, MD","credentials":["Professor of Psychiatry and Health Behavior \n","Medical College of Georgia"],"disclosure":"Grant/Research/Clinical Trial Support: Alkermes, Avanir, BoehringerIngleheim, Otsuka, Teva[SCHIZOPHRENIA (TARDIVE DYSKINESIA)].  Consultant/Advisory Boards: Jazz, Neurocrine, Teva [Schizophrenia (Olanzapine, clozapine)]."},{"name":"James R McKay, PhD","credentials":["Professor of Psychology in Psychiatry\n","University of Pennsylvania"],"disclosure":""},{"name":"Kimberly D McLaren, MD","credentials":["Assistant Professor of Health Services and Psychiatric Epidemiology\n","University of Washington Medical School"],"disclosure":""},{"name":"Katie McLaughlin, PhD","credentials":["Associate Professor, Department of Psychology\n","University of Washington"],"disclosure":""},{"name":"Philip Mehler, MD","credentials":["Chief Medical Officer, Eating Recovery Center\n","Executive Medical Director, ACUTE, Denver Health\n","Professor of Medicine, University of Colorado"],"disclosure":""},{"name":"Samantha Meltzer-Brody, MD, MPH","credentials":["Associate Professor and Associate Chair for Faculty Development\n","Director, UNC Perinatal Psychiatry Program\n","UNC Center for Women’s Mood Disorders"],"disclosure":"Grant/Research/Clinical Trial Support: Sage Pharmaceuticals [Postpartum depression (Investigational medication)]; Janssen [Postpartum depression (research)]."},{"name":"Lisa J Merlo, PhD, MPE","credentials":["Assoicate Professor of Psychiatry\n","University of Florida"],"disclosure":""},{"name":"James E Mitchell, MD","credentials":["Professor - Department of Psychiatry and Behavioral Science\n","University of North Dakota School of Medicine and Health Sciences\n","\n","Research Scientist\n","Neuropsychiatric Research Institute"],"disclosure":""},{"name":"Ramin Mojtabai, MD, PhD, MPH","credentials":["Professor of Mental Health\n","Johns Hopkins Bloomberg School of Public Health"],"disclosure":""},{"name":"C Scott Moreland, DO","credentials":["Clinical Assistant Professor\n","Baylor College of Medicine"],"disclosure":""},{"name":"Peter Na, MD","credentials":["New York University Department of Psychiatry"],"disclosure":""},{"name":"Craig Nelson, MD","credentials":["Professor of Psychiatry\n","University of California San Francisco"],"disclosure":"Grant/Research/Clinical Trial Support: Avid [PET imaging (Florbetapir)]. Consultant/Advisory Boards: Lundbeck [Depression (Brexpiprazole)]; Otsuka [Depression (Brexpiprazole)]; Janssen [Depression (esketamine)]; Assurex [Bipolar disorder (Genetic assay)]; Eisai [Insomnia (Lemborexant)]. Equity Ownership/Stock: Atossa [Breast cancer (Device)]. Other Honoraria: Otsuka Asia [Depression (Aripiprazole)]; Lundbeck [Depression (Brexpiprazole)]."},{"name":"Andrew Nierenberg, MD","credentials":["Professor of Psychiatry\n","Harvard Medical School, Massachusetts General Hospital"],"disclosure":"Grant/Research/Clinical Trial Support:  Takeda/Lundbeck [MDD (Vortioxetine)]; PamLabs [MDD (L-methylfolate)]; GlaxoSmithKlein [MDD (Lamotrigine, Bupropion)]; Alkermes [MDD (Naltrexone)]; NeuroRx Pharma [MDD (D-cycloserine, Lurasidone)]; PAREXEL [MDD (Pharmaceutical company, clinical research organization)]; Janssen Pharmaceuticals [Bipolar Disorder (longitudinal study in offspring of parents with BD)].  Consultant/Advisory Boards: Takeda/Lundbeck [MDD (Vortioxetine)]; Sunovian [MDD (Lurasidone)]; PamLabs [MDD (L-methylfolate)]; Naurex [MDD (GLX-13, NRX-1074)]; Hoffman La Roche/Genentech [MDD (R04917838)]; Eli Lilly and Company [MDD (Dulexetine)]; Pfizer [Desvenlafaxine]; NeuroRx Pharma [MDD/Bipolar Disorder]; Jazz Pharmaceuticals. Honoraria: SLACK Publishing [Publisher]; Physician’s Postgraduate Press, Inc. [Publisher]."},{"name":"Patrick G O'Connor, MD, MPH","credentials":["Professor of Medicine\n","Yale School of Medicine"],"disclosure":""},{"name":"Christine Pace, MD, MSc","credentials":["Assistant Professor of Medicine\n","Boston University School of Medicine"],"disclosure":""},{"name":"Tae Woo Park, MD, MSc","credentials":["Assistant Professor of Psychiatry\n","Boston University School of Medicine"],"disclosure":""},{"name":"Martin Paulus, MD","credentials":["Adjunct Professor of Psychiatry\n","University of California San Diego"],"disclosure":""},{"name":"Jennifer Payne, MD","credentials":["Associate Professor of Psychiatry\n","Johns Hopkins School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Sage Therapeutics [Postpartum depression (Allopregnanolone)]. Consultant/Advisory Boards: Sage Therapeutics [Postpartum depression (Allopregnanolone)]\r\nJanssen [Relapse Adjudication Committee (Esketamine, haloperidol, paliperidone, risperdone)]. Other Financial Interest: Eli Lily [Legal consulting (Duloxetine, fluoxetine, olanzapine)]; Abbott Pharmaceuticals [Legal consulting (fluvoxamine, valproic acid)]"},{"name":"Michelle Peavy","credentials":["Research and Training Manager\n","Evergreen Treatment Services"],"disclosure":""},{"name":"Mark J Petrini, MD","credentials":["Assistant Clinical Professor of Medicine and Psychiatry\n","Columbia University Medical Center"],"disclosure":""},{"name":"Katharine A Phillips, MD","credentials":["Professor of Psychiatry and Human Behavior\n","Warren Alpert Medical School of Brown University\n","Assistant Professor of Psychiatry \n","Weill Cornell Medical College (appointment to Professor in progress)"],"disclosure":"Other Financial Interest: Oxford University Press [Body dysmorphic disorder (royalties)]; Merck Manual [Obsessive compulsive and related disorders (honoraria)]; International Creative Management [Body dysmorphic disorder (agent for books)]; Guilford Publications [Body dysmorphic disorder (royalties)]; American Psychiatric Publishing [Obsessive-compulsive and related disorders (potential future royalties)], Royal Pharma [body dysmorphic disorder and olfactory reference syndrome (honorarium)], The Free Press [Body image in men (potential future royalties)]."},{"name":"Andrew A Pieper, MD, PhD","credentials":["Investigator, The Harrington Discovery Institute \n","\n","Professor of Psychiatry \n","Case Western Reserve University"],"disclosure":""},{"name":"Kathleen Pike, PhD","credentials":["Professor of Psychology and Psychiatry\n","Columbia University"],"disclosure":""},{"name":"Robert M Post, MD","credentials":["Clinical Professor of Psychiatry\n","George Washington University"],"disclosure":"Speaker's Bureau: AstraZeneca [Bipolar (Quetiapine)]; Sunovion [Bipolar (Lurasidone)]; Validus [Bipolar (Carbamazepine)]; Takeda [Unipolar (Vortioxetine)]; NestleHealthSci [Unipolar (L-methylfolate)]."},{"name":"Anthony Puliafico, PhD","credentials":["Assistant Professor of Medical Psychology (in Psychiatry)\n","Columbia University"],"disclosure":""},{"name":"Adam Rahman, MD, DABIM, FRCPC","credentials":["Assistant Professor of Medicine\n","University of Western Ontario"],"disclosure":""},{"name":"Charles L Raison, MD","credentials":["Professor, Department of Psychiatry\n","School of Medicine and Public Health\n","University of Wisconsin-Madison"],"disclosure":"Consultant/Advisory Boards: Usona Institute [Depression and anxiety (Psilocybin)]; Emory Healthcare,\r\n[wellbeing]; Lundback/Otsuka [bipolar disorder]; North American Center for Continuing Medical Education."},{"name":"Charles F Reynolds III, MD","credentials":["UPMC Endowed Professor in Geriatric Psychiatry\n","Director, Advanced Center for Interventions and Services Research in Late-Life Depression Prevention and Treatment, and the Hartford Center of Excellence in Geriatric Psychiatry\n","Director, Aging Institute of UPMC Senior Services and the University of P"],"disclosure":""},{"name":"Diana Robinson, MBBS FACSEP","credentials":["Chair and Chief Project Manager\n","Specialist Training Program Education Projects\n","Australasian College of Sport and Exercise Physicians"],"disclosure":""},{"name":"Daniel R Rosell, MD, PhD","credentials":["Assistant Professor of Psychiatry\n","Icahn School of Medicine at Mount Sinai"],"disclosure":""},{"name":"David Rosenberg, MD","credentials":["Professor and Chair of Psychiatry and Behavioral Neurosciences\n","Wayne State University"],"disclosure":""},{"name":"Barbara O Rothbaum, PhD","credentials":["Professor of Psychiatry\n","Emory University School of Medicine"],"disclosure":"Equity Ownership/Stock Options: Virtually Better [Virtual reality]."},{"name":"Anthony J Rothschild, MD","credentials":["Irving S. and Betty Brudnick Endowed Chair and Professor of Psychiatry \n","University of Massachusetts Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: NIMH [Psychotic depression (Sertraline, Olanzapine)]; Alkermes [Depression (ALKS-5461)]; Janssen [Depression (Esketamine)]; Takeda [Depression (Vortioxetine)]; Allergan [Depression (Rapastinel)]. Consultant/Advisory Boards: Eli Lilly [Depression, Suicide (Olanzapine)]; GlaxoSmithKline [Depression, Suicide (Paroxetine)]; Alkermes [Depression (ALK-5461); Sanofi [Insomnia (zolpidem)]; Sage Therapeutics [Depression (Sage-217)]."},{"name":"Peter P Roy-Byrne, MD","credentials":["Editor-in-Chief — Psychiatry\n","Section Editor — Depressive Disorders\n","Professor of Psychiatry and Behavioral Sciences\n","University of Washington School of Medicine"],"disclosure":"Employment: Mass Medical Society (journal Watch); Wiley Lliss (Depression and Anxiety) [Editor in Chief]. Stock Options: Valant Medical Solutions [behavioral health (EMR)]."},{"name":"John A Rush, MD","credentials":["Professor Emeritus\n","National University of Singapore, Duke-NUS"],"disclosure":"Speaker’s Bureau: Stanford University [Depression]; Global Medical Education Inc [Depression]; Sing-Health [Depression]; University of Montana [Depression]; John Peter Smith Health [Depression]. Consultant/Advisory Boards: Sunovion [Depression (Lurasidone)]; Brain Resource, Inc [Depression]; Curbstone Consultant LLC; Eli Lilly [Depression]; Emmes Corp [Substance use disorder]; Mind Linc [Depression]; Montana State University [Depression]; UT Southwestern Medical Center at Dallas [Mentoring]; Texas Tech [Mentoring]; Other Financial Support: Guilford Press (royalties); UT Southwestern (royalties)."},{"name":"Moira A Rynn, MD","credentials":["Professor of Psychiatry\n","Columbia University"],"disclosure":"Grant/Research/Clinical Trial Support: Shire [Anxiety (Guanfacine)]; NIMH [Anxiety (Minocycline)]."},{"name":"Richard Saitz, MD, MPH, FACP, DFASAM","credentials":["Section Editor — Substance Use Disorders\n","Professor of Community Health Sciences and Medicine\n","Boston University Schools of Public Health and Medicine, Boston Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Alkermes [Alkermes provides study medication for a clinical trial supported by NIH on Alcohol user disorder (injectable naltrexone)]."},{"name":"Martha Sajatovic, MD","credentials":["Director of Geriatric Psychiatry\n","Professor of Psychiatry\n","Case Western Reserve University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Alkermes (Long-acting injectable aripiprazole); Janssen [Schizophrenia (Paliperidone palmitate)]; Reuter Foundation [Schizophrenia (Haloperidol, paliperidone palmitate)]; Woodruff Foundation [Schizophrenia (Haloperidol, paliperidone palmitate)]; Reinberger Foundation [Schizophrenia (Haloperidol, paliperidone palmitate)]; National Institute of Health [Schizophrenia]. Consultant/Advisory Boards: Bracket [Rater training]; Otsuka [Schizophrenia and bipolar disorder]; Pfizer [Schizophrenia and bipolar disorder]; Sunovion [Schizophrenia and bipolar disorder (Lurasidone)]; Neurocrine [Parkinson's (Valbenazine)], Supernus [Bipolar Disorder (Carbamazepine)]. Other Financial Interest: Springer Press; Johns Hopkins University Press; Oxford Press (royalties)."},{"name":"Jitender Sareen, MD, FRCPC","credentials":["Professor and Department of Psychiatry, Max Rady College of Medicine, University of Manitoba"],"disclosure":"Equity Ownership/Stock Options: Johnson & Johnson."},{"name":"Rebecca J Schmidt, DO, FACP","credentials":["Professor of Medicine\n","West Virginia University School of Medicine"],"disclosure":""},{"name":"Franklin R Schneier, MD","credentials":["Special Lecturer in Psychiatry\n","Columbia University"],"disclosure":"Grant/Research/Clinical Trial Support: Allergan [Social anxiety disorder (Vilazodone)]."},{"name":"Jennifer Schreiber, MD","credentials":["Georgetown University Hospital"],"disclosure":""},{"name":"Peter H Schur, MD","credentials":["Editor-in-Chief — Rheumatology\n","Section Editor — Basic Science\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Zindel Segal, PhD, C.Psych","credentials":["Professor of Psychiatry \n","University of Toronto"],"disclosure":""},{"name":"Kevin Sevarino, MD","credentials":["Assistant Clinical Professor of Psychiatry\n","Yale University School of Medicine"],"disclosure":""},{"name":"Michael Sharpe, MD","credentials":["Professor of Psychological Medicine \n","University of Oxford"],"disclosure":""},{"name":"M Katherine Shear, MD","credentials":["Professor of Psychiatry\n","Columbia University"],"disclosure":"Grant/Research/Trial Support: Department of Defense, Congressionally Directed Research Programs [Interpersonal psychiatry (grant W81XWH-15-2-0043)]; New York Life Foundation [Interpersonal psychiatry]."},{"name":"Richard C Shelton, MD","credentials":["Charles Byron Ireland Chair\n","Professor and Vice Chair for Research\n","UAB Department of Psychiatry and Behavioral Neurobiology"],"disclosure":"Grant/Research/Clinical Trial Support: Acadia [Depression (Pimivanserin)] Alkermes [Depression (ALKS-5461)]; Allergan [Bipolar disorder (cariprazine, levomilnacipran, rapastinel)]; Assurex [Depression (Genetic test)]; Avanir [Depression (AVP-786)]; Cerecor [Depression (CERC-301)]; Janssen Pharmaceuticals [Depression (Eskatamine intranasal)]; Otsuka [Bipolar (Aripiprazole)]; Genomind (Genetic test). Consultant/Advisory Boards: Allergan [Depression (rapastinel, NRX1074)]; Cerecor [Depression (CERC-301; CERC-501)]; Janssen Pharmaceuticals [Depression (Eskatamine intranasal)]; MSI Methylation Sciences [Depression (S-adenosylmethione)]; Pfizer [Smoking cessation (Varenicline)]."},{"name":"Jonathan M Silver, MD","credentials":["Section Editor — Mental and Medical Disorders\n","Clinical Professor of Psychiatry\n","New York University School of Medicine"],"disclosure":""},{"name":"Daphne Simeon, MD","credentials":["Associate Clinical Professor\n","Mount Sinai School of Medicine"],"disclosure":""},{"name":"Gregory Simon, MD, MPH","credentials":["Kaiser Permanente Washington Health Research Institute \n","University of Washington Department of Psychiatry and Behavioral Sciences"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis Pharmaceuticals [Depression in psoriasis]."},{"name":"Naomi M Simon, MD, MSc","credentials":["Director, Anxiety and Complicated Grief Program\n","NYU Langone Health, NYU Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: American Foundation for Suicide Prevention; Department of Defense; Highland Street Foundation; NIH, Janssen. Speaker's Bureau: MGH Academy. Equity (spouse): G1Therapeutics, Gatekeeper."},{"name":"Helen Blair Simpson, MD, PhD","credentials":["Professor of Psychiatry\n","Columbia University Medical Center, College of Physicians and Surgeons, Columbia University"],"disclosure":"Grant/Research/Clinical Trial Support: Biohaven (investigational drug). Other Financial Interest: Cambridge University Press (royalties)."},{"name":"Samuel G Siris, MD","credentials":["Professor Emeritus of Psychiatry\n","Hofstra University/Northwell Health"],"disclosure":""},{"name":"Brian Skehan, MD, PhD","credentials":["Assistant Professor of Psychiatry and Pediatrics\n","University of Massachusetts Medical School"],"disclosure":""},{"name":"Andrew Skodol, MD","credentials":["Section Editor — Personality Disorders\n","Research Professor of Psychiatry\n","University of Arizona College of Medicine"],"disclosure":"Other Financial Interest: American Psychiatric Publishing (royalties); Merck Manuals (royalties)."},{"name":"Mary V Solanto, PhD","credentials":["Associate Professor of Psychiatry\n","NYU School of Medicine"],"disclosure":""},{"name":"David Solomon, MD","credentials":["Deputy Editor — Psychiatry\n","Clinical Associate Professor\n","Brown University School of Medicine"],"disclosure":""},{"name":"Joanna L Starrels, MD, MS","credentials":["Associate Professor of Medicine\n","Albert Einstein College of Medicine & Montefiore Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support:\tOpioid Postmarketing Requirement Consortium [co-investigator on an FDA-mandated multi-site observational study to examine the risks of extended-release/long-acting opioids]."},{"name":"Kristine Steffen, PharmD, PhD","credentials":["Research Scientist\n","Neuropsychiatric Research Institute"],"disclosure":"Grant/Research/Clinical Trial Support: [Bariatric surgery and pharmacokinetics (Lisdexamfetamine)]; NIH [Bariatric surgery and weight outcomes]; Sanford Profile/NDSU [Diabetes and microbiome]; Center for Protease Research/NDSU [Bariatric surgery and microbiome]."},{"name":"Murray B Stein, MD, MPH","credentials":["Editor-in-Chief — Psychiatry\n","Section Editor — Anxiety Disorders\n","Professor of Psychiatry and Family Medicine & Public Health\n","University of California San Diego"],"disclosure":"Grant/Research/Clinical Trial Support: Janssen [Social anxiety disorder]. Consultant/Advisory Boards: Actelion Pharmaceuticals [Anxiety and Traumatic Stress-Related Disorders]; Dart Neuroscience [Anxiety and Traumatic Stress-Related Disorders]; Janssen [Anxiety and Traumatic Stress-Related Disorders]; Oxeia Biopharmaceuticals [Traumatic Brain Injury]; Neurocrine [Tardive Dyskinesia]; Pfizer [Anxiety and Traumatic Stress-Related Disorders]. Equity Ownership/Stock Options: Oxeia Biopharmaceuticals [Traumatic Brain Injury]; Resilience Therapeutics [PTSD]."},{"name":"Joanna Steinglass, MD","credentials":["Assistant Professor of Clinical Psychiatry\n","Columbia University Medical Center/New York State Psychiatric Institute"],"disclosure":""},{"name":"Donna Stewart, CM, MD, FRCPC","credentials":["University Professor of Psychiatry, Ob-Gyn, Medicine, Surgery, Anesthesia, and Family and Community Medicine\n","University of Toronto and University Health Network"],"disclosure":"Consultant/Advisory Board: Eli Lilly [Depression during pregnancy (Duloxetine)]."},{"name":"Maxine Stitzer, PhD","credentials":["Professor of Psychiatry and Behavioral Sciences\n","Johns Hopkins University School of Medicine; Bayview Medical Center"],"disclosure":""},{"name":"Jon Stone, FRCP, PhD","credentials":["Honorary Reader in Neurology\n","University of Edinburgh"],"disclosure":""},{"name":"Jeffrey Stovall, MD","credentials":["Associate Professor of Psychiatry\n","Vanderbilt School of Medicine"],"disclosure":""},{"name":"Eric Strain, MD","credentials":["Director, Johns Hopkins Center for Substance Abuse Treatment and Research\n","Medical Director, Behavioral Pharmacology Research Unit\n","Johns Hopkins University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Alkermes [Opioid Use Disorder (naltrexone, buprenorphine, methadone)]. Consultant/Advisory Boards: Individior [Opioid use disorder (Buprenorphine)]; Egalet [Opioid use disorder]; Pinney Associates [Opioid use disorder]; The Oak Group [Opioid use disorder (Treatment placement decision sets)]. Other Financial Interest: Alkermes [Opioid use disorder]."},{"name":"Jeffrey Strawn, MD","credentials":["Associate Professor of Psychiatry\n","University of Cincinnati"],"disclosure":"Grant/Research/Clinical Trial Support: Edgemont [Adult generalized anxiety disorder (Extended-release lorazepam)]; Eli Lilly [Pediatric generalized anxiety disorder (Duloxetine)]; Forest Research Laboratories [Pediatric major depressive disorder (Vilazodone)]; Lundbeck [Adult PTSD]; Neuronetics [Pediatric major depressive disorder (Transcranial magnetic stimulation)]; National Institute of Mental Health [Neurofunctional predictors of treatment response in adolescents with generalized anxiety disorder treated with escitalopram]; Assurex Health [Generalized anxiety disorder (provided genotyping for a federally-funded study of escitalopram in children and adolescents with GAD)]. Royalties: Springer Publishing."},{"name":"T. Scott Stroup, MD, MPH","credentials":["Professor of Psychiatry\n","Columbia University"],"disclosure":"Research/Grant/Clinical Trial Support: Teva [Tardive dyskinesia (Deutetrabenazine)]."},{"name":"Kathryn N Suh, MD, FRCPC","credentials":["Associate Professor of Medicine\n","University of Ottawa, Canada"],"disclosure":""},{"name":"Trisha Suppes, MD","credentials":["Professor of Psychiatry & Behavioral Science\n","Stanford/VA Bipolar and Depression Research Program"],"disclosure":"Grant/Research/Clinical Trial Support: National Institute of Mental Health [Mood disorders (R34 moodswings)]; VA CSP [Mood disorders (Aripiprazole, Bupropion)]; Pathways Genomics [Mood disorders (Genetic testing)]; Stanley Medical Research Institute [Mood disorders (Infliximab)]; NIH (Mood Disorders); NIDA (Smoking Cessation); Palo Alto Health Sciences (PTSD). Consultant/Advisory Boards: Lundbeck [Mood disorders]; Merck [Mood disorders]; Sunovion [Mood disorders]; VA OR&D PRIME Care [Depression (Genetic testing)]. Other Financial Interest: Jones and Bartlett [royalties]; UpToDate [royalties]. Consultant/Advisory Boards: Sunovion [Mood disorders]."},{"name":"Holly A Swartz, MD","credentials":["Professor of Psychiatry\n","University of Pittsburgh School of Medicine"],"disclosure":""},{"name":"Mary M Sweeney, PhD","credentials":["Instructor of Psychiatry and Behavioral Sciences\n","Johns Hopkins University School of Medicine; Bayview Medical Center"],"disclosure":""},{"name":"Richard Swinson, MD","credentials":["Professor Emeritus\n","McMaster University"],"disclosure":""},{"name":"Robyn Sysko, PhD","credentials":["Assistant Professor of Psychiatry\n","Icahn School of Medicine at Mt. Sinai"],"disclosure":"Grant/Research/Clinical Trial Support: Shire Pharmaceuticals [Co-Investigator of Investigator Initiated Application funded to examine definitions of binge eating among patients with binge eating disorder (Lisdexamfetamine)]; Noom Inc. [Small business grant R42 DK116370-01 to use a randomized-controlled study to test the efficacy of a combined smartphone app and health coaching system (Noom Coach) to improve adherence, and behavioral/psychosocial outcomes for patients receiving bariatric surgery. \r\nRole: Co-Investigator; Bariatric surgery]. Consultant/Advisory Boards (spouse): Noom, Inc [Smartphone applications (Noom Monitor, a CBT Weightloss monitoring app developed as part of an NIMH small business grant R41MH096435 and currently being tested in a Phase II NIMH grant R42MH096435)]. Patent Holder (spouse): Noom, Inc [Smartphone applications (Noom Monitor, a CBT Weightloss monitoring app developed as part of an NIMH small business grant R41MH096435]."},{"name":"Puneeta Tandon, MD, FRCPC","credentials":["Associate Professor of Medicine\n","University of Alberta, Canada"],"disclosure":""},{"name":"Charles T Taylor, PhD","credentials":["Assistant Professor of Psychiatry\n","University of California San Diego"],"disclosure":""},{"name":"Scott A Teitelbaum, MD","credentials":["Professor of Psychiatry\n","University of Florida"],"disclosure":""},{"name":"Scott Temple, PhD","credentials":["Clinical Professor, Department of Psychiatry\n","University of Iowa Hospitals & Clinics"],"disclosure":""},{"name":"Jeanette M Tetrault, MD, FACP, FASAM","credentials":["Associate Professor of Medicine\n","Yale University School of Medicine"],"disclosure":""},{"name":"Michael Thase, MD","credentials":["Professor of Psychiatry\n","University of Pennsylvania School of Medicine"],"disclosure":"Grant/Research Support: Agency for Healthcare Research and Quality [Depression]; Alkermes [Depression]; Forest Pharmaceuticals [Depression (Vilazodone, Milnacipran)]; National Institute of Mental Health [Depression]; Otsuka Pharmaceuticals [Depression (Aripiprazole)]; PharmaNeuroboost [Depression]; Roche [Depression]; Johnson & Johnson [Depression (Risperidone, Esketamine)]; Avenir [Depression]. Consultant/Advisory Boards: Alkermes [Depression]; Allergan [Depression(Botulinium Toxin A)]; AstraZeneca [Depression (Quetiapine)]; Bristol-Myers Squibb [Depression (Aripiprazole)]; Cerecor [Depression (Olanzapine, Olanzapine Fluoxetine Combination, Duloxetine)]; Eli Lilly [Depression]; Forest Laboratories [Depression (Vilazodone Levomilnacipran)]; Gerson Lehrman Group [Depression]; GlaxoSmithKline [Depression]; Guidepoint Global [Depression]; H Lundbeck [Depression (Vortioxetine)]; MedAvante [Depression]; Merck [Depression (Mirtazapine)]; Moksha8 [Depression]; Neuronetics [Depression (Neurostar TMS Device)]; Novartis [Depression]; Johnson & Johnson [Depression (Risperidone, Esketamine]; Otsuka [Depression (Aripiprazole)]; Pamlab [Depression (L Methylfolate)]; Pfizer [Depression (Venlafaxine, Desvenlafaxine, Ziprasidone)]; PGx [Depression (Mixed Amphetamine Salts)]; Shire [Depression]; Sunovion Pharmaceuticals [Depression (Lurasidone)]; Takeda [Depression (Vortioxetine)]; Genentech [Depression]. Employment (Spouse): Peloton Advantage. Equity Ownership/ Stock Options: MedAvante."},{"name":"Kenneth Thompson, MD","credentials":["Clinical Associate Professor of Medicine\n","Pennsylvania State University"],"disclosure":""},{"name":"Geoffrey H Tofler, MD","credentials":["Professor of Cardiology\n","University of Sydney, Australia\n","Research Fellow\n","Harvard Medical School"],"disclosure":""},{"name":"Glenn J Treisman, MD, PhD","credentials":["Professor of Psychiatry and Behavioral Sciences, Professor of Medicine\n","Johns Hopkins University School of Medicine"],"disclosure":""},{"name":"Jürgen Unützer, MD, MPH","credentials":["Professor of Psychiatry\n","University of Washington"],"disclosure":""},{"name":"Michael Van Ameringen, MD","credentials":["Professor of Psychiatry and Behavioural Neurosciences\n","McMaster University"],"disclosure":"Grant/Research/Clinical Trial Support: Janssen-Ortho Inc [Depression (Sirukumab); Social Anxiety Disorder (JNJ-42165279)]; Pfizer Inc [Social Anxiety Disorder (sertraline)]; Servier [Generalized Anxiety Disorder (Agomelatine)]. Consultant/Advisory Boards: Janssen-Ortho Inc [ADHD (Methylphenidate)]; Lundbeck [ADHD (Methylphenidate)]; Purdue [Depression (Vortioxetine)]."},{"name":"John Vella, MD, FACP, FRCP, FASN, FAST","credentials":["Associate Professor of Medicine\n","Tufts University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas; Bristol Myers Squibb [Transplantation (CMV vaccine, belatacept)]."},{"name":"Eduard Vieta, MD, PhD","credentials":["Professor of Psychiatry\n","University of Barcelona"],"disclosure":"Grant/Research/Clinical Trial  Support: AB-Biotics [Bipolar Disorder (Pharmacogenetic Kit)]; Ferrer [Bipolar Disorder (Loxapine)]; Forest Research Institute [Bipolar Disorder (Cariprazine)]; Gedeon Richter [Bipolar Disorder (Cariprazine)]; Janssen [Bipolar Disprder (Esketamine)]; Lundbeck [Bipolar Disorder (Vortioxetine)]; Telefonica [Psychiatry (software)]. Consultant/Advisory Boards: AB-Biotics [Bipolar Disorder (Pharmacogenetic Kit)]; Allergan [Bipolar Disorder (Rapastinel)]; Dainippon Sumitomo Pharma [Bipolar Disorder (Lurasidone)]; Ferrer [Bipolar Disorder (Loxapine)]; Forest Research Institute [Bipolar Disorder (Cariprazine)]; Gedeon Richter [Bipolar Disorder (Cariprazine)]; Janssen [Bipolar Disprder (Esketamine)]; Lundbeck [Bipolar Disorder (Vortioxetine)]; Otsuka  [Bipolar Disorder (Aripiprazole depot)]; Sunovion [Bipolar Disorder (Lurasidone)]; Takeda [Bipolar Disorder (Vortioxetine)]; Telefonica [Psychiatry (software)]."},{"name":"Simone Vigod, MD, MSc, FRCPC","credentials":["Associate Professor of Psychiatry\n","University of Toronto"],"disclosure":""},{"name":"Adele Viguera, MD","credentials":["Director of Research, Women’s Mental Health; Assistant Professor in Psychiatry\n","Cleveland Clinic Lerner College of Medicine"],"disclosure":""},{"name":"Jeffrey Vittengl, PhD","credentials":["Professor of Psychology\n","Truman State University"],"disclosure":""},{"name":"John T Walkup, MD","credentials":["Director, Division of Child and Adolescent Psychiatry  \n","Vice Chair, Department of Psychiatry \n","Weill Cornell Medical College New York Presbyterian Hospital"],"disclosure":""},{"name":"B Timothy Walsh, MD","credentials":["Professor of Psychiatry\n","Columbia University"],"disclosure":""},{"name":"Elizabeth Weil, MD","credentials":["Associate Professor of Psychiatry\n","University of New Mexico School of Medicine"],"disclosure":""},{"name":"James C West, MD","credentials":["Associate Professor of Psychiatry\n","Uniformed Services University of the Health Sciences"],"disclosure":""},{"name":"Mark Zimmerman, MD","credentials":["Associate Professor of Psychiatry\n","Brown University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Alkermes [Depression]. Other Financial Interest: Otsuka Pharmaceuticals [Licensing fee]."},{"name":"Sidney Zisook, MD","credentials":["Distinguished Professor of Psychiatry\n","UC San Diego"],"disclosure":""},{"name":"Christie Zunker, PhD, CPH, CHES","credentials":["Evaluation Scientist at ICF International"],"disclosure":""}]},{"name":"Peer Reviewers","contributors":[{"name":"Elias Aboujaoude, MD","credentials":["Clinical Professor\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Steve Adelman, MD","credentials":["Clinical Associate Professor of Psychiatry\n","University of Massachusetts School of Medicine"],"disclosure":""},{"name":"Daniel Alford, MD, MPH","credentials":["Associate Professor of Medicine\n","Boston University School of Medicine"],"disclosure":""},{"name":"Evelyn Attia, MD","credentials":["Professor of Psychiatry\n","Columbia University Medical Center"],"disclosure":"Grant/Research Support: Eli Lilly [Eating disorders (Olanzapine)]."},{"name":"David Avery, MD","credentials":["Professor of Psychiatry and Behavioral Sciences\n","University of Washington School of Medicine"],"disclosure":""},{"name":"Catherine Ayers, PhD","credentials":["Assistant Professor\n","UC San Diego School of Medicine"],"disclosure":""},{"name":"Richard Balon, MD","credentials":["Professor (Clinical) of Psychiatry and Anesthesiology\n","Wayne State University School of Medicine"],"disclosure":""},{"name":"Steven L Batki, MD","credentials":["Professor of Psychiatry, University of California, San Francisco\n","Chief, Substance Abuse Programs and Director, Addiction  Research Program, San Francisco VA Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Alkermes Inc [Alcohol pharmacotherapy (Extended-release naltrexone injection)]. Consultant/Advisory Boards: Alkermes Inc [Alcohol pharmacotherapy (Extended-release naltrexone injection)]."},{"name":"Boris Birmaher, MD","credentials":["Endowed Chair in Early Onset Bipolar Disease, Professor of Psychiatry\n","University of Pittsburgh, School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: National Institutes of Mental Health [Bipolar disorder]. Other Financial Interests: Royalties for books [Bipolar and major depressive disorders]."},{"name":"Michael H Bloch, MD, MS","credentials":["Assistant Professor\n","Yale Child Study Center"],"disclosure":"Grant/Research/Clinical Trial Support: Neurocrine Biosciences [Tourette syndrome (valbenazine)]; Janssen Pharmaceuticals [Depression (esketamine)]. Consultant/Advisory Boards: Therapix Biosciences [Tourette syndrome]."},{"name":"Hillary R Bogner, MD, MSCE","credentials":["Assistant Professor\n","University of Pennsylvania"],"disclosure":""},{"name":"Bethany Brand, PhD","credentials":["Professor of Psychology \n","Towson University"],"disclosure":""},{"name":"Robert W Buchanan, MD","credentials":["Professor of Psychiatry\n","University of Maryland School of Medicine"],"disclosure":""},{"name":"Leah Casuto, MD","credentials":["Adjunct Assistant Professor of Psychiatry-COM, Department of Psychiatry & Behavioral Neuroscience\n","University of Cincinnati College of Medicine"],"disclosure":""},{"name":"Les Citrome, MD","credentials":["Clinical Professor of Psychiatry and Behavioral Sciences\n","New York Medical College"],"disclosure":"Speaker’s Bureau: Acadia [Parkinson's Disease psychosis (pimavanserin)]; Alkermes [schizophrenia (aripiprazole lauroxil); Allergan [schizophrenia, bipolar mania (asenapine, cariprazine)]; Janssen [schizophrenia, schizoaffective disorder (paliperidone palmitate)]; Lundbeck [schizophrenia, major depressive disorder(brexpiprazole, aripiprazole monohydrate)]; Merck [insomnia (suvorexant)]; Neurocrine [tardive dyskinesia (valbenazine)]; Otsuka [schizophrenia, major depressive disorder, bipolar disorder (brexpiprazole, aripiprazole monohydrate, aripiprazole)]; Pfizer [schizophrenia, bipolar disorder (ziprasidone)]; Shire [binge eating disorder (lisdexamfetamine)]; Sunovion [schizophrenia, bipolar disorder (lurasidone)]; Takeda [major depressive disorder (vortioxetine)]; Teva [tardive dyskinesia (deutetrabenazine)]; Vanda [schizophrenia (iloperidone)]. Consultant/Advisory Boards: Acadia [Parkinson's Disease psychosis (pimavanserin)];  Alkermes [schizophrenia (aripiprazole lauroxil)]; Allergan [schizophrenia, bipolar mania (asenapine, cariprazine)]; Boehringer Ingelheim [schizophrenia (investigational drug)]; Forum [schizophrenia (investigational drug)]; Genentech [schizophrenia (investigational drug)]; Intra-Cellular Therapeutics [schizophrenia (investigational drug)]; Janssen [schizophrenia, schizoaffective disorder (paliperidone palmitate)]; Lundbeck [schizophrenia, major depressive disorder(brexpiprazole, aripiprazole monohydrate)]; Merck [insomnia (suvorexant)];  Neurocrine [tardive dyskinesia (valbenazine)]; Noven [schizophrenia (investigational drug)]; Otsuka [schizophrenia, major depressive disorder, bipolar disorder (brexpiprazole, aripiprazole monohydrate, aripiprazole)]; Pfizer [schizophrenia, bipolar disorder (ziprasidone)]; Reckitt Benckiser [schizophrenia (investigational drug)]; Reviva  [schizophrenia (investigational drug)]; Shire [binge eating disorder (lisdexamfetamine)]; Sunovion [schizophrenia, bipolar disorder (lurasidone)]; Teva [tardive dyskinesia (deutetrabenazine)]; Vanda [schizophrenia (iloperidone)]. Equity Ownership/Stock Options: Bristol-Myers Squibb; Eli Lilly; Johnson & Johnson; Merck; Pfizer."},{"name":"Heidi Combs, MD, MS","credentials":["Associate Professor of Psychiatry and Behavioral Sciences\n","University of Washington School of Medicine"],"disclosure":""},{"name":"Daniel F Connor, MD","credentials":["Lockean Distinguished Professor of Psychiatry\n","Chief Division of Child & Adolescent Psychiatry\n","Univ"],"disclosure":"Consultant/Advisory Boards: Shire [ADHD (stimulants)]; Supernus [Aggression (molindone)]."},{"name":"Deborah Cowley, MD","credentials":["Professor of Psychiatry and Behavioral Sciences\n","University of Washington"],"disclosure":""},{"name":"Scott J Crow, MD","credentials":["Professor of Psychiatry\n","University of Minnesota"],"disclosure":""},{"name":"Michael Devlin, MD","credentials":["Professor of Clinical Psychiatry\n","Columbia University College of Physicians and Surgeons"],"disclosure":""},{"name":"Peter Freed, MD","credentials":["Assistant Professor of Clinical Psychiatry\n","Columbia University"],"disclosure":""},{"name":"Oliver Freudenreich, MD","credentials":["Associate Professor of Psychiatry\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Avanir [Schizophrenia (AVP-786)]; Janssen [Schizophrenia (long-acting injectable)]; Otsuka [Schizophrenia (brexpiprazole)]. Consultant/Advisory Boards: Janssen [Schizophrenia drug development]. Other Financial Interest: Global Medical Education [CME talk on schizophrenia]."},{"name":"Manuel Fuentes, MD","credentials":["Assistant Professor\n","Psychiatry Department\n","Faculty of Medicine Clínica Alemana/Universidad del Desarrollo"],"disclosure":""},{"name":"David R Gastfriend, MD","credentials":["Scientific Advisor\n","Treatment Research Institute"],"disclosure":"Grant/Research/Clinical Support: Treatment Research Institute [Medication assisted treatment (American Society of Addiction Medicine criteria)]; PCORI [Medication assisted treatment (American Society of Addiction Medicine criteria)]; DynamiCareHealth. Consultant/Advisory Boards: Alkermes [Addiction (naltrexone)]; BioCorRx [Addiction (naltrexone)]; Indivior [Addiction (buprenorphine)]; Kaleo [Addiction (naloxone auto-injector)]; Purdue Pharma [Addiction]. Employment: DynamiCare Health [Addiction (Contingency management)]. Equity Ownership/Stock Options: Alkermes (naltrexone); DynamiCare Health [Addiction (Contingency management applications)]. Other Financial Interest: American Society of Addiction Medicine (Continuum Royalties)."},{"name":"Bradley N Gaynes, MD, MPH","credentials":["Professor of Psychiatry, Associate Chair for Psychiatry Research Training and Education \n","University of North Carolina School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: M-3 [Research to assess feasibility of administering a general psychiatric screening and monitoring tool in psychiatric clinics]."},{"name":"Michael Gitlin, MD","credentials":["Professor of Clinical Psychiatry\n","Geffen School of Medicine at UCLA"],"disclosure":""},{"name":"Benjamin Goldstein, MD, PhD, FRCP","credentials":["Associate Professor of Psychiatry, Pharmacology, and Psychological Clinical Science\n","University of Toronto"],"disclosure":""},{"name":"Paul Grekin, MD","credentials":["Clinical Professor of Psychiatry\n","University of Washington Medical School"],"disclosure":""},{"name":"Ceri Hadda, MD","credentials":["Assistant Clinical Professor of Psychiatry\n","NYU School of Medicine"],"disclosure":""},{"name":"Victoria Hendrick, MD","credentials":["Clinical Professor\n","Department of Psychiatry and Biobehavioral Sciences David Geffen School of Medicine, UCLA"],"disclosure":""},{"name":"Philip G Janicak, MD","credentials":["Adjunct Professor, Department of Psychiatry and Behavioral Sciences\n","Northwestern University, Feinberg School of Medicine"],"disclosure":"Speaker's Bureau: Neuronetics [Depression (transcranial magnetic stimulation)]; TMS Solutions [Depression (transcranial magnetic stimulation)]. Consultant/ Advisory Boards: Neuronetics [Depression (transcranial magnetic stimulation)]; Otsuka [Psychosis (participate in their nonpromotional PsyhU program on various topics, including mood and psychotic disorders)]."},{"name":"Danielle Johnson, MD, FAPA","credentials":["Adjunct Assistant Professor of Psychiatry\n","University of Cincinnati College of Medicine/Lindner Center of HOPE"],"disclosure":""},{"name":"Courtney Kassar, MD","credentials":["Assistant Professor of Psychiatry\n","University of Cincinnati, Lindner Center of Hope"],"disclosure":""},{"name":"Ryan Kimmel, MD","credentials":["Associate Professor of Psychiatry and Behavioral Sciences\n","University of Washington School of Medicine"],"disclosure":""},{"name":"Nicole Lanouette, MD","credentials":["Associate Clinical Professor\n","Department of Psychiatry\n","Medical Director, Neuropsychiatry and Behavioral Medicine Services, UCSD"],"disclosure":""},{"name":"Roberto Lewis-Fernandez, MD","credentials":["Professor of Psychiatry, Columbia University Medical Center\n","Director of the NY State Center of Excellence for Cultural Competence and the Hispanic Treatment Program, NYS Psychiatric Institute"],"disclosure":"Equity Ownership/Stock Options: GlaxoSmithKline."},{"name":"Richard J Loewenstein, MD","credentials":["Medical Director, The Trauma Disorders Program\n","Sheppard Pratt Health System"],"disclosure":""},{"name":"Shari I Lusskin, MD, FAPA","credentials":["Clinical Professor of Psychiatry, Obstetrics, Gynecology, and Reproductive Sciences \n","Icahn School of Medicine at Mount Sinai\n","Attending\n","Mount Sinai Medical Center"],"disclosure":"Employment: Reproductive Toxicology Foundation, Director of Psychopharmacologic Agents. Other Financial Interest: Pfizer [Consultant regarding sertraline and venlafaxine litigation (Sertraline, venlafazine)]); Forest Laboratories [Consultant regarding escitalopram litigation (Escitalopram)]."},{"name":"Sloan Manning, MD","credentials":["Adjunct Associate Professor\n","University of North Carolina, School of Medicine"],"disclosure":"Speaker's Bureau: Lundbeck [Mood disorders in primary care (Vortioxetine)]; Otsuka [Mood disorders in primary care (Brexpiprazole)]; Sunovion [Mood disorders in primary care (Lurasidone)]; Takeda [Mood disorders in primary care (Vortioxetine)]. Consultant/Advisory Boards: Lundbeck [Mood disorders in primary care (Vortioxetine)]; Otsuka [Mood disorders in primary care (Brexpiprazole)]; Sunovion [Mood disorders in primary care (Lurasidone)]; Takeda [Mood disorders in primary care (Vortioxetine)] Sunovion ADHD in primary care (dasotraline)"},{"name":"Theo Manschreck, MD","credentials":["Professor of Psychiatry\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Otsuka [early psychosis (aripiprazole)]. Consultant/Advisory Boards: Otsuka-Lundbeck [new antidepressant]."},{"name":"Joseph O Merrill, MD, MPH","credentials":["Associate Professor of Medicine               \n","University of Washington School of Medicine"],"disclosure":""},{"name":"Erik Messamore, MD, PhD","credentials":["Assistant Professor of Psychiatry\n","University of Cincinnati"],"disclosure":""},{"name":"Karen Miotto, MD","credentials":["Professor of Psychiatry\n","UCLA School of Medicine"],"disclosure":""},{"name":"James E Mitchell, MD","credentials":["Professor - Department of Psychiatry and Behavioral Science\n","University of North Dakota School of Medicine and Health Sciences\n","\n","Research Scientist\n","Neuropsychiatric Research Institute"],"disclosure":""},{"name":"Pauline S Powers, MD","credentials":["Professor of Psychiatry Emerita\n","University of South Florida College of Medicine"],"disclosure":"Employment: Fairwinds Treatment Center."},{"name":"Jitender Sareen, MD, FRCPC","credentials":["Professor and Department of Psychiatry, Max Rady College of Medicine, University of Manitoba"],"disclosure":"Equity Ownership/Stock Options: Johnson & Johnson."},{"name":"Jason J Schafer, PharmD, BCPS, AAHIVP","credentials":["Assistant Professor, Department of Pharmacy Practice\n","The Jefferson School of Pharmacy, Thomas Jefferson University"],"disclosure":""},{"name":"Tracey G Skale, MD","credentials":["Chief Medical Officer, Greater Cincinnati Behavioral Health Services\n","Volunteer Faculty, University of Cincinnati College of Medicine"],"disclosure":"Consultant/Advisory Boards: Otsuka [Schizophrenia (Long-acting injection aripiprazole)]. Speaker’s Bureau: Sunovion [Schizophrenia/bipolar disorder (lurasidone)]; Otsuka/Lundbeck [Schizophrenia (Aripiprazole, brexpiprazole)]."},{"name":"Scott H Stewart, MD, MS","credentials":["Associate Professor of Medicine\n","University at Buffalo, State University of New York"],"disclosure":""},{"name":"T. Scott Stroup, MD, MPH","credentials":["Professor of Psychiatry\n","Columbia University"],"disclosure":"Research/Grant/Clinical Trial Support: Teva [Tardive dyskinesia (Deutetrabenazine)]."},{"name":"Thomas N Wise, MD","credentials":["Professor of Psychiatry\n","Johns Hopkins University School of Medicine \n","George Washington School of Medicine (Associate Chair)"],"disclosure":""},{"name":"Mark Zimmerman, MD","credentials":["Associate Professor of Psychiatry\n","Brown University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Alkermes [Depression]. Other Financial Interest: Otsuka Pharmaceuticals [Licensing fee]."}]}]}